@gpollara.bsky.social
Infectious Diseases doctor (at UCLH) and academic (at UCL). Research focuses on host-pathogen interactions in TB, leprosy and UTIs. What are the immune, epithelial and stromal cell responses involved, and could they be targets for host-directed therapies?
@gpollara.bsky.social
@jennyrohn.bsky.socialReposted by @gpollara.bsky.socialCloses tonight at 23:59! Last chance to apply for this #job with @gpollara.bsky.social and me! 👇
@jennyrohn.bsky.socialReposted by @gpollara.bsky.social@gpollara.bsky.social🚨 NEW RESEARCH TECHNICIAN POST 🚨
👉 Interested in understanding the biology of recurrent UTI?
👉 Keen to work in my own and @jennyrohn.bsky.social research groups at UCL?
Then please do take a look at new position available 👇. Informal enquiries encouraged.
#UTISky
@gpollara.bsky.socialyes, that is true as well, agree.
@gpollara.bsky.socialMore diagnostic tests don't always = better or reduced antibiotic prescribing. Well, not CRP in primary care anyway!
#IDSky #ClinMicro @jac-amr.bsky.social
academic.oup.com/jacamr/artic...
@gpollara.bsky.socialAgree game changing!
Notable to me that unlike OVIVA, this will really need to be a partnership change of doing things with orthopaedic teams - surgery itself will need local antibiotic delivery devices planned etc... Not a bad thing at all, it's not an ID-only stewardship change of practice #IDSky
@germhuntermd.bsky.socialReposted by @gpollara.bsky.socialLess is more, ortho-ID edition
Another game changer in ortho ID from the group that brought you OVIVA
Pts with ortho infections who underwent curative surgery (no DAIR) with local implantation of abx were randomized to <=7d vs >=4w ABx
No Dif in 12 mo relapse
@gpollara.bsky.socialMasterful drive and use of DRS!
@gpollara.bsky.socialIs the destination photo as critical?! 😉
@gpollara.bsky.socialObligatory "en route" photo to EMBO "the complexity of mycobacterial infections" meeting in Paris.
Looking forward to presenting some of our work on leprosy reaction immunopathogenesis.
#embocomplexinfections @embo.org #TBSky #leprosy
@gpollara.bsky.socialexcellent coverage. enjoy the off season, though sure you'll be doing other commentary!
@gpollara.bsky.socialexcellent summary that!
@anhhle2702.bsky.socialReposted by @gpollara.bsky.socialVery happy to share my postdoc paper is out now in @natcellbio.nature.com titled "Tissue flow acts as a guidance cue for immune cell polarization and directional migration". If you love imaging and immune cells, this is for you! #microscopymonday
www.nature.com/articles/s41...
A 🧵: 1/n
@josephmarcusid.medsky.socialReposted by @gpollara.bsky.socialAntimicrobial use in ECMO is poorly described.
We evaluated AU at our center and found, despite no ECMO specific ppx protocol, antimicrobials were prescribed on 85% of pt days😱
Also my teams first use of a bubble plot 🫧
@gpollara.bsky.socialthat may be true, but it would be a consultation with a very clear end goal of getting a MRI. Hard to steer a patient away from that if that was their entry into the appointment.
@gpollara.bsky.socialTerrible advert on London Underground. How about booking an appointment to speak to a human doctor to discuss medical concerns?
@gpollara.bsky.socialYou may be better off just having a separate browser tab. We can definitely make a journal club hashtag-led feed @skyfeed.app or @skyfeed.eu , super easy, but it's not perfect at pulling in all posts and there's definitely a bit of a delay.
@gpollara.bsky.socialTBH i don't think we need to - if there is hashtag discipline, which there should be, then easiest thing is just to click on the hashtag. Much simpler than making a feed?
@gpollara.bsky.socialnice work Chris!
